Learning curve of MRI-based planning for high-dose-rate brachytherapy for prostate cancer

After introduction of MRI-based HDRBT, procedure times were significantly reduced. D90 Clinical target volumeprostate+3mm fulfilled constraints in most patients and improved over time, but not at expense of an increased urethral or rectal dose.